VOLUME 65   2004   SUPPLEMENT 18

ARTICLES

3 Metabolic Syndrome: Epidemiology and Consequences. Frank M. Sacks
[Abstract] [PDF]

13 Schizophrenia and Obesity: Impact of Antipsychotic Medications. Donna A. Wirshing
[Abstract] [PDF]

27 Dyslipidemia and Atypical Antipsychotic Drugs. Daniel E. Casey
[Abstract] [PDF]

36 Abnormalities of Glucose Metabolism Associated With Atypical Antipsychotic Drugs. John W. Newcomer
[Abstract] [PDF]

47 A Comparison of Weight Change During Treatment With Olanzapine or Aripiprazole: Results From a Randomized, Double-Blind Study. Robert D. McQuade, Elyse Stock, Ron Marcus, Darlene Jody, Neveen A. Gharbia, Simon Vanveggel, Don Archibald, and William H. Carson
[Abstract] [PDF]